pembrolizumab,nivolumab,ipilimumab,atezolizumab
bms,merck,roche
['cm-914', 'nivolumab', 'pembro', 'rcc,(-irccs),(-srcc),(-urcc)', 'immotion010', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'kn-564', 'sarcoma', 'nivo', 'prosper,trial']
adjuvant therapies in rcc
matthew r. zibelman -what matters to patients and clinicians?
-differences... similarities between trials?
#gu23 #medtwitter #kidney 
On the road!
Pursuing to improve global health through sharing knowledge, cancer prevention, and care.  
Medical oncologist @AnkaraUni